PLX8394 Uses, Dosage, Side Effects and more
PLX8394 is under investigation in clinical trial NCT02428712 (A Study of PLX8394 as a Single Agent in Patients With Advanced Unresectable Solid Tumors).
| Trade Name | PLX8394 |
| Generic | PLX8394 |
| Type | |
| Formula | C25H21F3N6O3S |
| Weight | Average: 542.54 Monoisotopic: 542.134794223 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
